Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05790460 · ClinicalTrials.gov registry record · NA
Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung Cancer
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT05790460 is a NA study that was terminated before completion, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 55 participants.
The verdict
NCT05790460, a NA study, was terminated before completion, sponsored by Abramson Cancer Center at Penn Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The goal of this trial is to design and test a telehealth nurse navigation intervention for patients with suspected locally advanced/metastatic NSCLC to improve timely molecularly-informed treatment recommendations through early integration of concurrent molecular testing.
Interventions
- OTHER Telehealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2024-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05790460
The ClinicalTrials.gov registry entry for NCT05790460 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telehealth is the first listed.
NCT05790460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05790460 about?
NCT05790460 is a clinical study titled "Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung Cancer". The goal of this trial is to design and test a telehealth nurse navigation intervention for patients with suspected locally advanced/metastatic NSCLC to improve timely molecularly-informed treatment recommendations through early integration of concurrent molecular testing.
What is the current status of trial NCT05790460?
This trial is currently terminated. It is a NA study. The enrollment target is 55 participants. The study started on 2023-05-08. Estimated completion is 2024-11-09.
What interventions are being tested in trial NCT05790460?
The interventions under investigation include: Telehealth (OTHER).
Who is sponsoring clinical trial NCT05790460?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.